NO20022057L - Fremgangsmåte og sammensetning for å behandle lungesykdommer - Google Patents

Fremgangsmåte og sammensetning for å behandle lungesykdommer

Info

Publication number
NO20022057L
NO20022057L NO20022057A NO20022057A NO20022057L NO 20022057 L NO20022057 L NO 20022057L NO 20022057 A NO20022057 A NO 20022057A NO 20022057 A NO20022057 A NO 20022057A NO 20022057 L NO20022057 L NO 20022057L
Authority
NO
Norway
Prior art keywords
composition
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
NO20022057A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022057D0 (no
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20022057D0 publication Critical patent/NO20022057D0/no
Publication of NO20022057L publication Critical patent/NO20022057L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20022057A 1999-11-02 2002-04-30 Fremgangsmåte og sammensetning for å behandle lungesykdommer NO20022057L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (2)

Publication Number Publication Date
NO20022057D0 NO20022057D0 (no) 2002-04-30
NO20022057L true NO20022057L (no) 2002-06-27

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022057A NO20022057L (no) 1999-11-02 2002-04-30 Fremgangsmåte og sammensetning for å behandle lungesykdommer

Country Status (29)

Country Link
EP (1) EP1225866A4 (pt)
JP (1) JP2003513028A (pt)
KR (1) KR20020057988A (pt)
CN (1) CN1387404A (pt)
AP (1) AP2002002496A0 (pt)
AR (1) AR029189A1 (pt)
AU (1) AU1357501A (pt)
BG (1) BG106748A (pt)
BR (1) BR0015270A (pt)
CA (1) CA2388333A1 (pt)
CO (1) CO5261512A1 (pt)
CZ (1) CZ20021512A3 (pt)
DZ (1) DZ3225A1 (pt)
EA (1) EA200200518A1 (pt)
EC (1) ECSP003747A (pt)
HK (1) HK1049107A1 (pt)
HU (1) HUP0203152A3 (pt)
IL (1) IL149367A0 (pt)
MA (1) MA26841A1 (pt)
MX (1) MXPA02004350A (pt)
NO (1) NO20022057L (pt)
OA (1) OA12076A (pt)
PE (1) PE20011005A1 (pt)
PL (1) PL355261A1 (pt)
SK (1) SK7592002A3 (pt)
TR (1) TR200201211T2 (pt)
TW (1) TWI242431B (pt)
WO (1) WO2001032127A2 (pt)
ZA (1) ZA200203435B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282469T3 (es) 2001-09-19 2007-10-16 Nycomed Gmbh Combinacion de un nsaid y un inhibidor de pde-4.
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. 医薬組成物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
CA2626628A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CN104338219B (zh) 2010-01-05 2017-10-24 微剂量治疗技术公司 吸入设备和方法
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433997T2 (de) * 1993-06-18 2005-01-27 Smithkline Beecham Corp. Verfahren zur Identifizierung eines PDE IV Hemmers
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
HK1049107A1 (zh) 2003-05-02
WO2001032127A3 (en) 2001-12-06
MXPA02004350A (es) 2002-11-07
TWI242431B (en) 2005-11-01
AU1357501A (en) 2001-05-14
HUP0203152A3 (en) 2004-06-28
CA2388333A1 (en) 2001-05-10
JP2003513028A (ja) 2003-04-08
SK7592002A3 (en) 2002-11-06
EP1225866A4 (en) 2004-04-21
ECSP003747A (es) 2002-05-23
NO20022057D0 (no) 2002-04-30
BR0015270A (pt) 2002-06-18
PE20011005A1 (es) 2001-09-28
DZ3225A1 (fr) 2001-05-10
PL355261A1 (en) 2004-04-05
MA26841A1 (fr) 2004-12-20
WO2001032127A2 (en) 2001-05-10
CN1387404A (zh) 2002-12-25
CZ20021512A3 (cs) 2003-04-16
ZA200203435B (en) 2003-06-25
IL149367A0 (en) 2002-11-10
KR20020057988A (ko) 2002-07-12
EA200200518A1 (ru) 2002-10-31
TR200201211T2 (tr) 2002-08-21
AP2002002496A0 (en) 2002-06-30
OA12076A (en) 2006-05-04
AR029189A1 (es) 2003-06-18
HUP0203152A2 (hu) 2003-01-28
EP1225866A2 (en) 2002-07-31
CO5261512A1 (es) 2003-03-31
BG106748A (en) 2003-02-28

Similar Documents

Publication Publication Date Title
NO20012916D0 (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20012344D0 (no) Sammensetninger og fremgangsmåter for å kontrollere plantepester
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
NO20013193D0 (no) Fremgangsmåte og kit for å ekstrahere prionprotein
NO20025627L (no) Fremgangsmåter og sammensetninger for å behandle hepatitt C virus
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20015764L (no) Fremgangsmåte og preparat for å maskere mineralsmak
NO20022057L (no) Fremgangsmåte og sammensetning for å behandle lungesykdommer
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO20013752D0 (no) Beregningssystem og fremgangsmåte for å modellere hjertet
NO20005763D0 (no) DHEA-sammensetning og metode
IL150963A0 (en) Method and compositions for treating an inflammatory disease
NO20014569D0 (no) Fremgangsmåte og sammensetning for kontroll av lus
EP1261331A4 (en) METHOD AND COMPOSITIONS FOR TREATING FIBROSANT DISEASES
DE60028609D1 (de) Zusammensetzung zum entfernen von knitterfalten und entsprechendes behandlungsverfahren
NO20022990L (no) Fremgangsmåte og sammensetning for behandling av smerte
NO20010191D0 (no) Forbindelser, materialer og fremgangsmåter for å stimulere neuronal vekst og elongering
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
ATE366573T1 (de) Neue behandlungsmethode
DK199801152A (da) Fremgangsmåde til opdræt af svin og svinesti til brug ved udøvelse af fremgangsmåden
NO20005080D0 (no) FremgangsmÕte og anordning for maskinell oppdeling av flatfisk i porsjonsstykker
NO20022482D0 (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
DK1200446T3 (da) Oxathiepino[6,5-b]dihydropyridiner og beslægtede forbindelser og fremgangsmåder

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application